Study Title

Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm

Study Details

Description:

This phase II trial studies how well F-18 fluoroethyltyrosine (fluoroethyltyrosine) works in detecting tumors in participants with intracranial tumors that have come back. Imaging agents, such as fluoroethyltyrosine, may help doctors see the tumor better during a positron emission tomography (PET) scan.

Sponsor:

University of California, San Francisco

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468